glp-1 companies Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Receptor Agonist Market Size

The FDA has received reports of adverse events, including hospitalizations, associated with compounded injectable semaglutide tied to dosing errors

GLP-1 medications provide important safety information on their websites, including possible side effects from taking the drug

5 However, not all small-molecule GLP-1R agonists have advanced successfully

Demand has grown rapidly Public interest in GLP-1 medications has expanded rapidly

One simple price, two medication pathways

Some evidence suggests that these medications may be able to help some people binge less, but experts do not yet recommend them as a replacement for traditional mental health therapy, and more research is necessary before healthcare professionals would consider them a standard part of treatment